RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1480
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1432200; Gene model (P.falciparum): PF3D7_1216500; Gene product: male development gene 1 | protein of early gametocyte 3 (MDV-1; PEG3; MDV-1/PEG3)
Name tag: BirA*::3xMyc
Phenotype Gametocyte/Gamete;
Last modified: 6 July 2016, 17:57
  *RMgm-1480
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 27371728
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherKehrer J; Frischknecht F, Mair GR
Name Group/DepartmentUniversity of Heidelberg Medical School
Name InstituteUniversity of Heidelberg Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-1480
Principal nameMDV1/PEG3::BirA*::myc
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteUsing an anti-myc antibody the MDV1/PEG3::BirA*::myc protein is readily identified by immunofluorescence revealing its gametocyte-specific localization in the mutant with an abundant and typical localization for osmiophilic bodies.
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal BirA*-myc-tagged version of MDV1/PEG3.

Protein (function)
The protein is a gametocyte specific protein and has been named in P. falciparum MDV-1 (male development gene 1) or PEG3. In P. falciparum gametocytes the protein is associated with the osmiophilic bodies, the parasite membrane and all membranous compartments derived from the parasitophorous vacuole membrane. P. falciparum parasites lacking expression of MDV-1/PEG3 were affected in their capacity to produce functional gametocytes, which were unable to be transmitted through mosquitoes.
The phenotype analyses of a P. berghei mutant lacking expression of MDV1/PEG3 (RMgm-282) indicate that the lack of expression of MDV-1/PEG3 strongly impairs fertilisation and ookinete formation and that the decreased fertilisation rate results from a strongly reduced capacity of both male and female gametocytes/gametes to egress from their host erythrocytes. The results indicate that MDV-1/PEG3 plays a role in disruption of the parasitophorous vacuole membrane (PVM) and the erythrocyte membrane.

Phenotype
Using an anti-myc antibody the MDV1/PEG3::BirA*::myc protein is readily identified by immunofluorescence revealing its gametocyte-specific localization in the mutant with an abundant and typical localization for osmiophilic bodies.

Additional information
This mutant is used in a study aiming at identifying 'gametocyte regressome', i.e. proteins that are released when Plasmodium gametes escape from their host reythrocyte. For the release of mature extracellular gametes two membrane barriers - the parasite parasitophorous vacuole membrane and the host red blood cell membrane - need to be dissolved. Membrane lysis occurs after the release of proteins from specialized secretory vesicles including osmiophilic bodies.
The identified Plasmodium gametocyte egressome includes the proteins released by the parasite during the lysis of the parasitophorous vacuole membrane and red blood cell membrane. BioID of the osmiophilic body protein MDV1/PEG3 revealed a proteome of these gametocyte-specific secretory vesicles. For bioID the mutated biotin ligase BirA* from Escherichia coli was fused to MDV1/PEG3. BioID relies on the fusion of a protein of interest with a mutated BirA ligase (BirA*) that in the presence of excess biotin biotinylates nearby proteins, which can be purified by affinity chromatography using streptavidin.
Fluorescent protein tagging and gene deletion approaches were employed to validate and identify a set of novel factors essential for this lysis and egress process.

Other mutants
See this link for other mutants generated in this study.
See also other MDV1/PEG3 mutants.


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1432200
Gene Model P. falciparum ortholog PF3D7_1216500
Gene productmale development gene 1 | protein of early gametocyte 3
Gene product: Alternative nameMDV-1; PEG3; MDV-1/PEG3
Details of the genetic modification
Name of the tagBirA*::3xMyc
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe 3’ end 661 bps of the MDV1/PEG3 (PBANKA_143220) ORF were PCR-amplified as 2 adjacent products with primers g3094 and g3095, and g3096 and g3097, digested with EcoRI, ligated, and re-amplified with primers g3094 and g3096, thus introducing a unique EcoRI-site in the middle of the amplicon. After digestion with SspI and BamHI the PCR product was ligated in frame with BirA*-cmyc into a plasmid containing the human DHFR selection marker. Prior to transfection the plasmid pLIS0297 was linearised with EcoRI.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6